[Involvement of dendritic cells frequency and function in outcomes of interferon-alpha therapy for chronic hepatitis

Yan-Li Zhang1, Feng Liu, Ming-Hui Li

  • 1Liver Center of Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China.

Insights

Interferon-alpha therapy for chronic hepatitis B (CHB) increases plasmacytoid dendritic cell (pDC) frequency and function in responders. Myeloid dendritic cell (mDC) frequency and function decrease in non-responders, indicating their role in treatment outcomes.

Area of Science:

  • Immunology
  • Hepatology
  • Virology

Background:

  • Chronic hepatitis B (CHB) is a significant global health concern.
  • Interferon-alpha (IFN-alpha) is a treatment option for CHB.
  • Dendritic cells (DCs), including myeloid (mDC) and plasmacytoid (pDC) subsets, play crucial roles in immune responses.

Purpose of the Study:

  • To investigate the changes in mDC and pDC frequencies and functions during IFN-alpha therapy in CHB patients.
  • To correlate these DC changes with virological and biochemical treatment responses.

Main Methods:

  • Flow cytometry was used to analyze peripheral blood mDC and pDC frequencies and CD86 expression in 30 HBeAg-positive CHB patients before and after 12 weeks of IFN-alpha therapy.
  • Patients were stratified into groups based on alanine aminotransferase (ALT) normalization and virological response.

Main Results:

  • In patients with normalized ALT, pDC frequency increased significantly post-therapy (P=0.023).
  • In non-normalized ALT patients, mDC frequency and CD86 expression decreased significantly (P=0.025, P=0.036).
  • In virological responders, pDC CD86 expression increased (P=0.002), while in non-responders, mDC frequency and CD86 expression decreased significantly (P=0.006, P=0.049).

Conclusions:

  • Increased pDC frequency and function correlate with biochemical and virological response to IFN-alpha therapy in CHB.
  • Decreased mDC frequency and function are associated with non-response to IFN-alpha therapy in CHB.
  • These findings highlight the differential roles of mDC and pDC subsets in predicting IFN-alpha treatment outcomes for CHB.
Abstract

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...